The global ketamine treatment market is anticipated to grow at a significant CAGR of 43.7% during the forecast period (2024-2031). The market growth is primarily driven by the prevalence of treatment-resistant depression. Additionally, the development of innovative formulations and delivery methods to enhance safety and efficacy is also contributing to the market growth. Furthermore,...